A universal DNA aptamer as an efficient inhibitor against spike-protein/hACE2 interactions.
Chem Commun (Camb)
; 58(58): 8049-8052, 2022 Jul 19.
Article
in English
| MEDLINE | ID: covidwho-1908311
ABSTRACT
A universal aptamer against spike-proteins of diverse SARS-CoV-2 variants was discovered via DNA SELEX towards the wild-type (WT) spike-protein. This aptamer, A1C1, binds to the WT spike-protein or other variants of concern such as Delta and Omicron with low nanomolar affinities. A1C1 inhibited the interaction between hACE2 and various spike-proteins by 85-89%. This universal A1C1 aptamer can be used to design diagnostic and therapeutic molecular tools to target SARS-CoV-2 and its variants.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Aptamers, Nucleotide
/
COVID-19
Topics:
Variants
Limits:
Humans
Language:
English
Journal:
Chem Commun (Camb)
Journal subject:
Chemistry
Year:
2022
Document Type:
Article
Affiliation country:
D2cc02647c
Similar
MEDLINE
...
LILACS
LIS